SAM CHUN DANG PHARM CO. LTD financial statements, including revenue, expenses, and profit
The total revenue of 000250 for the last quarter is 55.19 B KRW, and it's 5.37% higher compared to the previous quarter. The net income of Q4 24 is -7.78 B KRW.